Metabolic syndrome in children

Experimental and Therapeutic Medicine

Volumn 12, Issue 4, 2016, Pages 2390-2394

  Wu, Yue E ^a   Zhang, Chong Lin ^a   Zhen, Qing ^a  

^a XUZHOU CHILDREN S HOSPITAL   (China)

Author keywords

Cardiometabolic risk factors; Infants; Metabolic syndrome

Indexed keywords

ALANINE AMINOTRANSFERASE; GAMMA GLUTAMYLTRANSFERASE; PATATIN LIKE PHOSPHOLIPASE DOMAIN CONTAINING PROTEIN 3; PROTEIN; UNCLASSIFIED DRUG;

ABDOMINAL OBESITY; ATHEROSCLEROSIS; CARDIOMETABOLIC RISK; CARDIORESPIRATORY FITNESS; CHILDHOOD OBESITY; CORONARY ARTERY ATHEROSCLEROSIS; DIET; DISEASE ASSOCIATION; DYSLIPIDEMIA; ELEVATED BLOOD PRESSURE; FATTY LIVER; GLUCOSE INTOLERANCE; HEREDITY; HUMAN; HYPERGLYCEMIA; INSULIN RESISTANCE; LIPID STORAGE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; OVARY POLYCYSTIC DISEASE; OVERNUTRITION; PEDIATRICS; PHYSICAL ACTIVITY; REVIEW; SEDENTARY LIFESTYLE; SLEEP DISORDERED BREATHING; SMOKING; SOCIAL PSYCHOLOGY; SOCIAL STATUS; TRANSIENT ISCHEMIC ATTACK;

EID: 84987957273     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2016.3632     Document Type: Review

References (66)

1. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM and Smith SC Jr; International Diabetes Federation Task Force on Epidemiology and Prevention; Hational Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; International Association for the Study of Obesity: Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120: 1640-1645, 2009.
2. Kassi E, Pervanidou P, Kaltsas G and Chrousos G: Metabolic syndrome: definitions and controversies. BMC Med 9: 48, 2011. doi: 10.1186/1741-7015-9-48.
3. Flegal KM, Carroll MD, Kit BK and Ogden CL: Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010. JAMA 307: 491-497, 2012.
4. Morrison JA, Friedman LA and Gray-McGuire C: Metabolic syndrome in childhood predicts adult cardiovascular disease 25 years later: The Princeton Lipid Research Clinics Follow-up Study. Pediatrics 120: 340-345, 2007.
5. Morrison JA, Friedman LA, Wang P and Glueck CJ: Metabolic syndrome in childhood predicts adult metabolic syndrome and type 2 diabetes mellitus 25 to 30 years later. J Pediatr 152: 201-206, 2008.
6. McNeill AM, Rosamond WD, Girman CJ, Golden SH, Schmidt MI, East HE, Ballantyne CM and Heiss G: The metabolic syndrome and 11-year risk of incident cardiovascular disease in the atherosclerosis risk in communities study. Diabetes Care 28: 385-390, 2005.
7. Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J and Salonen JT: The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 288: 2709-2716, 2002.
8. Eisenmann JC, Laurson KR, DuBose KD, Smith BK and Donnelly JE: Construct validity of a continuous metabolic syndrome score in children. Diabetol Metab Syndr 2: 8, 2010.
9. Pandit D, Chiplonkar S, Khadilkar A, Kinare A and Khadilkar V: Efficacy of a continuous metabolic syndrome score in Indian children for detecting subclinical atherosclerotic risk. Int J Obes 35: 1318-1324, 2011.
10. Hillier TA, Rousseau A, Lange C, Lépinay P, Cailleau M, Novak M, Calliez E, Ducimetière P and Balkau B; D.E.S.I.R. Cohort: Practical way to assess metabolic syndrome using a continuous score obtained from principal components analysis. Diabetologia 49: 1528-1535, 2006.
11. Boyraz M, Hatipoglu N, Sari E, Akcay A, Taskin N, Ulucan K, Akcay T: Non-alcoholic fatty liver disease in obese children and the relationship between metabolic syndrome criteria. Obes Res Clin Pract 8: e356-e363, 2014.
12. Widhalm K and Ghods E: Nonalcoholic fatty liver disease: a challenge for pediatricians. Int J Obes 34: 1451-1467, 2010.
13. Giorgio V, Prono F, Graziano F and Nobili V: Pediatric non alcoholic fatty liver disease: old and new concepts on development, progression, metabolic insight and potential treatment targets. BMC Pediatr 13: 40, 2013. doi: 10.1186/1471-2431-13-40.
14. Rodríguez G, Gallego S, Breidenassel C, Moreno LA and Gottrand F: Is liver transaminases assessment an appropriate tool for the screening of non-alcoholic fatty liver disease in at risk obese children and adolescents? Nutr Hosp 25: 712-717, 2010.
15. Sale MM, Woods J and Freedman BI: Genetic determinants of the metabolic syndrome. Curr Hypertens Rep 8: 16-22, 2006.
16. Terán-García M and Bouchard C: Genetics of the metabolic syndrome. Appl Physiol Nutr Metab 32: 89-114, 2007.
17. Pankow JS, Jacobs DR Jr, Steinberger J, Moran A and Sinaiko AR: Insulin resistance and cardiovascular disease risk factors in children of parents with the insulin resistance (metabolic) syndrome. Diabetes Care 27: 775-780, 2004.
18. Bao W, Srinivasan SR, Valdez R, Greenlund KJ, Wattigney WA and Berenson GS: Longitudinal changes in cardiovascular risk from childhood to young adulthood in offspring of parents with coronary artery disease: The Bogalusa Heart Study. JAMA 278: 1749-1754, 1997.
19. Pietiläinen KH, Bergholm R, Rissanen A, Kaprio J, Häkkinen AM, Sattar N and Yki-Järvinen H: Effects of acquired obesity on endothelial function in monozygotic twins. Obesity (Silver Spring) 14: 826-837, 2006.
20. Nocon M, Hiemann T, Müller-Riemenschneider F, Thalau F, Roll S and Willich SN: Association of physical activity with all-cause and cardiovascular mortality: a systematic review and meta-analysis. Eur J Cardiovasc Prev Rehabil 15: 239-246, 2008.
21. Pereira S and Pereira D: Metabolic syndrome and physical activity. Acta Med Port 24: 785-790, 2011 (In Portuguese).
22. Rauner A, Mess F and Woll A: The relationship between physical activity, physical fitness and overweight in adolescents: a systematic review of studies published in or after 2000. BMC Pediatr 13: 19, 2013. doi: 10.1186/1471-2431-13-19.
23. Väistö J, Eloranta AM, Viitasalo A, Tompuri T, Lintu N, Karjalainen P, Lampinen EK, Ågren J, Laaksonen DE, Lakka HM, et al: Physical activity and sedentary behaviour in relation to cardiometabolic risk in children: cross-sectional findings from the Physical Activity and Nutrition in Children (PANIC) Study. Int J Behav Nutr Phys Act 11: 55, 2014. doi: 10.1186/1479-5868-11-55.
24. Lutsey PL, Steffen LM and Stevens J: Dietary intake and the development of the metabolic syndrome: The atherosclerosis risk in communities study. Circulation 117: 754-761, 2008.
25. Pasanisi F, Contaldo F, de Simone G and Mancini M: Benefits of sustained moderate weight loss in obesity. Nutr Metab Cardiovasc Dis 11: 401-406, 2001.
26. Ilanne-Parikka P, Eriksson JG, Lindström J, Peltonen M, Aunola S, Hämäläinen H, Keinänen-Kiukaanniemi S, Laakso M, Valle TT, Lahtela J, et al; Finnish Diabetes Prevention Study Group: Effect of lifestyle intervention on the occurrence of metabolic syndrome and its components in the Finnish Diabetes Prevention Study. Diabetes Care 31: 805-807, 2008.
27. Orchard TJ, Temprosa M, Goldberg R, Haffner S, Ratner R, Marcovina S and Fowler S; Diabetes Prevention Program Research Group: The effect of metformin and intensive lifestyle intervention on the metabolic syndrome: The Diabetes Prevention Program randomized trial. Ann Intern Med 142: 611-619, 2005.
28. Eloranta AM, Lindi V, Schwab U, Kiiskinen S, Venäläinen T, Lakka HM, Laaksonen DE and Lakka TA: Dietary factors associated with metabolic risk score in Finnish children aged 6-8 years: the PANIC study. Eur J Nutr 53: 1431-1439, 2014.
29. Sookoian S and Pirola CJ: Epigenetics of insulin resistance: an emerging field in translational medicine. Curr Diab Rep 13: 229-237, 2013.
30. Burguet A: Long-term outcome in children of mothers with gestational diabetes. Diabetes Metab 36: 682-694, 2010.
31. Yu M, Xu CX, Zhu HH, Hu RY, Zhang J, Wang H, He QF, Su DT, Zhao M, Wang LX, et al: Associations of cigarette smoking and alcohol consumption with metabolic syndrome in a male Chinese population: a cross-sectional study. J Epidemiol 24: 361-369, 2014.
32. Tamashiro KL: Metabolic syndrome: links to social stress and socioeconomic status. Ann N Y Acad Sci 1231: 46-55, 2011.
33. Abbasi F, Brown BW Jr, Lamendola C, McLaughlin T and Reaven GM: Relationship between obesity, insulin resistance, and coronary heart disease risk. J Am Coll Cardiol 40: 937-943, 2002.
34. Laakso M and Kuusisto J: Insulin resistance and hyperglycaemia in cardiovascular disease development. Nat Rev Endocrinol 10: 293-302, 2014.
35. DeFronzo RA and Tripathy D: Skeletal muscle insulin resistance is the primary defect in type 2 diabetes. Diabetes Care 32 (Suppl 2): S157-S163, 2009.
36. Michael MD, Kulkarni RN, Postic C, Previs SF, Shulman GI, Magnuson MA and Kahn CR: Loss of insulin signaling in hepatocytes leads to severe insulin resistance and progressive hepatic dysfunction. Mol Cell 6: 87-97, 2000.
37. Yki-Järvinen H: Glucose toxicity. Endocr Rev 13: 415-431, 1992.
38. Begg DP and Woods SC: The endocrinology of food intake. Nat Rev Endocrinol 9: 584-597, 2013.
39. Olivieri O, Bassi A, Stranieri C, Trabetti E, Martinelli N, Pizzolo F, Girelli D, Friso S, Pignatti PF and Corrocher R: Apolipoprotein C-III, metabolic syndrome, and risk of coronary artery disease. J Lipid Res 44: 2374-2381, 2003.
40. Borén J, Taskinen MR, Olofsson SO and Levin M: Ectopic lipid storage and insulin resistance: a harmful relationship. J Intern Med 274: 25-40, 2013.
41. Packard CJ, Demant T, Stewart JP, Bedford D, Caslake MJ, Schwertfeger G, Bedynek A, Shepherd J and Seidel D: Apolipoprotein B metabolism and the distribution of VLDL and LDL subfractions. J Lipid Res 41: 305-318, 2000.
42. Tooke JE and Hannemann MM: Adverse endothelial function and the insulin resistance syndrome. J Intern Med 247: 425-431, 2000.
43. Salonen JT, Lakka TA, Lakka HM, Valkonen VP, Everson SA and Kaplan GA: Hyperinsulinemia is associated with the incidence of hypertension and dyslipidemia in middle-aged men. Diabetes 47: 270-275, 1998.
44. Vogel RA: Cholesterol lowering and endothelial function. Am J Med 107: 479-487, 1999.
45. Laaksonen DE, Niskanen L, Nyyssönen K, Lakka TA, Laukkanen JA and Salonen JT: Dyslipidaemia as a predictor of hypertension in middle-aged men. Eur Heart J 29: 2561-2568, 2008.
46. Comar JF, de Oliveira DS, Bracht L, Kemmelmeier FS, Peralta RM and Bracht A: The metabolic responses to L-glutamine of livers from rats with diabetes types 1 and 2. PLOS ONE 11: e160067, 2016.
47. Lebovitz HE: Type 2 diabetes: An overview. Clin Chem 45: 1339-1345, 1999.
48. Kawada T: Serum granzyme-B, insulin resistance, metabolic syndrome and cardiovascular risk: Statistical validity for risk assessment. Eur J Obstet Gynecol Reprod Biol: Jul 30, 2016 (Epub ahead of print).
49. Juutilainen A, Kortelainen S, Lehto S, Rönnemaa T, Pyörälä K and Laakso M: Gender difference in the impact of type 2 diabetes on coronary heart disease risk. Diabetes Care 27: 2898-2904, 2004.
50. Juutilainen A, Lehto S, Rönnemaa T, Pyörälä K and Laakso M: Proteinuria and metabolic syndrome as predictors of cardio­vascular death in non-diabetic and type 2 diabetic men and women. Diabetologia 49: 56-65, 2006.
51. Reinehr T: Type 2 diabetes mellitus in children and adolescents. World J Diabetes 4: 270-281, 2013.
52. Giudice EM, Grandone A, Cirillo G, Santoro N, Amato A, Brienza C, Savarese P, Marzuillo P and Perrone L: The asso­ciation of PNPLA3 variants with liver enzymes in childhood obesity is driven by the interaction with abdominal fat. PLoS One 6: e27933, 2011.
53. Goran MI, Walker R, Le KA, Mahurkar S, Vikman S, Davis JN, Spruijt-Metz D, Weigensberg MJ and Allayee H: Effects of PNPLA3 on liver fat and metabolic profile in Hispanic children and adolescents. Diabetes 59: 3127-3130, 2010.
54. McNeill AM, Rosamond WD, Girman CJ, Heiss G, Golden SH, Duncan BB, East HE and Ballantyne C: Prevalence of coronary heart disease and carotid arterial thickening in patients with the metabolic syndrome (The ARIC Study). Am J Cardiol 94: 1249-1254, 2004.
55. Ash-Bernal R and Peterson LR: The cardiometabolic syndrome and cardiovascular disease. J Cardiometab Syndr 1: 25-28, 2006.
56. Raitakari OT, Juonala M, Kähönen M, Taittonen L, Laitinen T, Mäki-Torkko N, Järvisalo MJ, Uhari M, Jokinen E, Rönnemaa T, et al: Cardiovascular risk factors in childhood and carotid artery intima-media thickness in adulthood: the Cardiovascular Risk in Young Finns Study. JAMA 290: 2277-2283, 2003.
57. Juonala M, Järvisalo MJ, Mäki-Torkko N, Kähönen M, Viikari JS and Raitakari OT: Risk factors identified in childhood and decreased carotid artery elasticity in adulthood: The Cardiovascular Risk in Young Finns Study. Circulation 112: 1486-1493, 2005.
58. Wong ND, Sciammarella MG, Polk D, Gallagher A, Miranda-Peats L, Whitcomb B, Hachamovitch R, Friedman JD, Hayes S and Berman DS: The metabolic syndrome, diabetes, and subclinical atherosclerosis assessed by coronary calcium. J Am Coll Cardiol 41: 1547-1553, 2003.
59. Koren-Morag N, Goldbourt U and Tanne D: Relation between the metabolic syndrome and ischemic stroke or transient ischemic attack: a prospective cohort study in patients with atherosclerotic cardiovascular disease. Stroke 36: 1366-1371, 2005.
60. Grundy SM: Metabolic syndrome: connecting and reconciling cardiovascular and diabetes worlds. J Am Coll Cardiol 47: 1093-1100, 2006.
61. Legro RS, Arslanian SA, Ehrmann DA, Hoeger KM, Murad MH, Pasquali R and Welt CK; Endocrine Society: Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 98: 4565-4592, 2013.
62. Legro RSA: A 27-year-old woman with a diagnosis of polycystic ovary syndrome. JAMA 297: 509-519, 2007.
63. Drager LF, Togeiro SM, Polotsky VY and Lorenzi-Filho G: Obstructive sleep apnea: a cardiometabolic risk in obesity and the metabolic syndrome. J Am Coll Cardiol 62: 569-576, 2013.
64. Schulz R, Eisele HJ, Reichenberger F and Seeger W: Obstructive sleep apnoea and metabolic syndrome. Pneumologie 62: 88-91, 2008 (In German).
65. Hamilton GS, Solin P and Naughton MT: Obstructive sleep apnoea and cardiovascular disease. Intern Med J 34: 420-426, 2004.
66. Guh DP, Zhang W, Bansback N, Amarsi Z, Birmingham CL and Anis AH: The incidence of co-morbidities related to obesity and overweight: a systematic review and meta-analysis. BMC Public Health 9: 88, 2009. doi: 10.1186/1471-2458-9-88.